Published in Cell Immunol on October 01, 1972
Active suppression as a possible mechanism of tolerance in tetraparental mice. J Exp Med (1973) 1.25
The in vitro effects of Bordetella pertussis lymphocytosis-promoting factor on murine lymphocytes: II. Nature of the responding cells. J Exp Med (1977) 1.23
Induction of interferon in mice by mycoplasmas. Infect Immun (1974) 0.97
Adoptive transfer of variant-specific resistance to Trypanosoma rhodesiense with B lymphocytes and serum. Infect Immun (1976) 0.94
Characterization of the blastogenic response of C58 spleen cells: age-dependent changes. Immunology (1974) 0.86
Alterations in mouse macrophage migration: a function of assay systems, lymphocyte activation product preparation, and fractionation. Infect Immun (1975) 0.83
Mechanisms in the suppression of delayed hypersensitivity in the guinea pig by 6-mercaptopurine. J Exp Med (1973) 0.83
Immunological tolerance. Dissociation between in vivo and in vitro reactivity in parabiosed mice. J Exp Med (1974) 0.80
Suppression of in vitro antibody response of human peripheral blood lymphocytes by a heat-labile factor in normal human serum. Clin Exp Immunol (1981) 0.75
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med (2000) 11.90
Uncertainty in xenotransplantation: individual benefit versus collective risk. Nat Med (1998) 3.54
Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg (1968) 3.34
Recall of early menstrual history and menarcheal body size: after 30 years, how well do women remember? Am J Epidemiol (2002) 3.11
Immunologic rejection of human cancer transplanted with a renal allograft. N Engl J Med (1968) 2.70
Host defenses in experimental scrub typhus: role of cellular immunity in heterologous protection. Infect Immun (1976) 2.60
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med (1995) 2.48
Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med (1970) 2.43
Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation. N Engl J Med (1972) 2.33
Long-term body-weight-supported treadmill training and subsequent follow-up in persons with chronic SCI: effects on functional walking ability and measures of subjective well-being. Spinal Cord (2005) 2.18
Intrarenal distribution of blood flow in the transplanted dog kidney: effect of denervation and rejection. J Clin Invest (1967) 2.14
Cytomegalovirus infection after renal allotransplantation. JAMA (1967) 2.08
Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN. Br J Cancer (1998) 2.06
Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis. N Engl J Med (1967) 2.06
Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med (1984) 2.03
Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase. Proc Natl Acad Sci U S A (1972) 2.01
Postexercise net protein synthesis in human muscle from orally administered amino acids. Am J Physiol (1999) 2.00
Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection. Nature (1987) 1.99
The modulating influence of cyclic nucleotides upon lymphocyte-mediated cytotoxicity. J Exp Med (1973) 1.92
Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro. Proc Natl Acad Sci U S A (1972) 1.85
Subtotal parathyroidectomy in chronic renal failure: a seven-year experience in a dialysis and transplant program. Ann Surg (1971) 1.83
Identity and cytotoxic capacity of cells infiltrating renal allografts. N Engl J Med (1975) 1.82
Urine fibrinogen fragments in human renal allografts. A possible mechanism of renal injury. N Engl J Med (1968) 1.80
Survival of patients undergoing chronic hemodialysis and renal transplantation. N Engl J Med (1973) 1.74
Serum complement component levels in human glomerulonephritis. Ann Intern Med (1971) 1.70
Maternal-fetal relation. Absence of an immunologic blocking factor from the serum of women with chronic abortions. N Engl J Med (1976) 1.69
Schistosomiasis in the congenitally athymic (nude) mouse. I. Thymic dependency of eosinophilia, granuloma formation, and host morbidity. J Immunol (1977) 1.68
Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann Intern Med (1983) 1.68
Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2. J Immunol (1990) 1.67
Human renal isografts: a clinical and pathologic analysis. Medicine (Baltimore) (1968) 1.63
Coagulation studies in the hyperacute and other forms of renal-allograft rejection. N Engl J Med (1969) 1.62
Secondary hyperparathyroidism and renal osteodystrophy in chronic renal failure. Analysis of 195 patients, with observations on the effects of chronic dialysis, kidney transplantation and subtotal parathyroidectomy. Medicine (Baltimore) (1969) 1.61
Isolated testicular vasculitis mimicking a testicular neoplasm. J Clin Pathol (1994) 1.59
Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res (1995) 1.57
Renal transplantation in the inbred rat. 3. A study of heterologous anti-thymocyte sera. J Exp Med (1967) 1.57
Glomerulonephritis (third of three parts). N Engl J Med (1974) 1.52
Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A (1996) 1.51
The role of antibodies in the rejection and enhancement of organ allografts.?7318. Adv Immunol (1976) 1.48
Factors contributing to the declining mortality rate in renal transplantation. N Engl J Med (1978) 1.45
Avoidance of cyclosporine in renal transplantation: effects of daclizumab, mycophenolate mofetil, and steroids. J Am Soc Nephrol (2000) 1.45
Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J Clin Invest (1978) 1.44
Senescence and the renal vasculature in normal man. Circ Res (1974) 1.43
Alterations in human serum beta-1C-gobulin (C'3) in renal transplantation. Am J Med (1967) 1.42
Testosterone injection stimulates net protein synthesis but not tissue amino acid transport. Am J Physiol (1998) 1.40
Intravascular coagulation (IVC) in human renal allograft rejection. Transplant Proc (1969) 1.39
Immunologic aspects of host responses to schistosomiasis: resistance, immunopathology, and eosinophil involvement. Prog Allergy (1978) 1.39
The role of nonclassical Fc receptor-associated, Ag-B antigens (Ia) in rat allograft enhancement. J Exp Med (1976) 1.33
Simplified hippuran clearance. Measurement of renal function in man with simplified hippuran clearances. Nephron (1966) 1.33
Delayed hypersensitivity granuloma formation and modulation around Schistosoma mansoni eggs in vitro. II. Regulatory T cell subsets. J Immunol (1982) 1.31
Effect of chronic renal failure and hemodialysis on carbohydrate metabolism. J Clin Invest (1966) 1.30
Improved B cell typing for HLA-DR using nylon wool column enriched B lymphocyte preparations. Tissue Antigens (1979) 1.29
Early-onset pauciarticular juvenile rheumatoid arthritis associated with human leukocyte antigen-DRw5, iritis, and antinuclear antibody. J Clin Invest (1980) 1.29
Synthetic polypeptide metabolism. 3. Degradation and organ localization of isomeric synthetic polypeptide antigens. J Immunol (1967) 1.28
Two genes required for diabetes in BB rats. Evidence from cyclical intercrosses and backcrosses. J Exp Med (1984) 1.28
Hereditary C2 deficiency: diagnosis and HLA gene complex associations. J Immunol (1976) 1.28
Induction of mouse type-C RNA virus by lipopolysaccharide. J Immunol (1975) 1.28
Tropical diseases of importance to the traveler. Adv Intern Med (1984) 1.28
Acute oliguric renal failure in man: evidence for preferential renal cortical ischemia. Medicine (Baltimore) (1968) 1.28
Body weight supported treadmill training in acute spinal cord injury: impact on muscle and bone. Spinal Cord (2005) 1.26
Active suppression as a possible mechanism of tolerance in tetraparental mice. J Exp Med (1973) 1.25
Effects of leucine and its metabolite β-hydroxy-β-methylbutyrate on human skeletal muscle protein metabolism. J Physiol (2013) 1.25
Renal transplantation in the inbred rat. I. Morphologic, immunologic, and functional alterations during acute rejection. Transplantation (1967) 1.22
Sauna baths in the treatment of chronic renal failure. Trans Am Soc Artif Intern Organs (1966) 1.22
Mapping of the structural gene for the second component of complement with respect to the human major histocompatibility complex. Am J Hum Genet (1979) 1.22
Cell-mediated immunity in interstitial nephritis. III. T lymphocyte-mediated fibroblast proliferation and collagen synthesis: an immune mechanism for renal fibrogenesis. J Immunol (1980) 1.22
Cellular adaptation to repeated eccentric exercise-induced muscle damage. J Appl Physiol (1985) (2001) 1.22
Editoral: Cardiovascular disease in dialysis patients. N Engl J Med (1974) 1.20
Uremic pericarditis. Clinical features and management. Circulation (1968) 1.20
Human renal allografts. Interpretation of morphologic and immunohistochemical observations. Am J Pathol (1968) 1.19
An immunosupressive site of action of heterologous antilymphocyte serum. Lancet (1967) 1.17
Effect of mercaptans and other agents on the human complement component beta-1c-globulin. Immunology (1966) 1.17
Liver disease in kidney transplant patients receiving azathioprine. Arch Intern Med (1973) 1.15
Renal transplantation in the inbred rat. II. An immunohistochemical study of acute allograft rejection. Am J Pathol (1968) 1.14
Lymphokine modulation of fibroblast proliferation. J Immunol (1982) 1.14
Disappearance of "uremic" itching after subtotal parathyroidectomy. N Engl J Med (1968) 1.13
Effect of sodium balance on intrarenal distribution of blood flow in normal man. J Appl Physiol (1970) 1.13
Cellular components of allograft rejection: identity, specificity, and cytotoxic function of cells infiltrating acutely rejecting allografts. J Immunol (1977) 1.12
Cell-mediated immunity in interstitial nephritis. I. T lymphocyte systems in nephritic guinea pigs: the natural history and diversity of the immune response. J Immunol (1979) 1.12
Cellular immunity in the mouse. II. Correlation of in vivo and in vitro phenomena. Cell Immunol (1972) 1.12
Hepatitis affecting hemodialysis and transplant patients. Its considerations and consequences. Arch Intern Med (1973) 1.11
Delayed hypersensitivity granuloma formation around Schistosoma mansoni eggs in vitro. I. Definition of the model. J Immunol (1982) 1.11
Vestibular toxicity of gentamicin. Incidence in patients receiving long-term hemodialysis therapy. Arch Intern Med (1978) 1.10
Rejected human renal allografts: recovery and characteristics of infiltrating cells and antibody. Transplantation (1979) 1.10
Role of indirect allorecognition in allograft rejection. Int Rev Immunol (1996) 1.10
Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation (1997) 1.10
Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J Exp Med (1995) 1.10
Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat. Proc Natl Acad Sci U S A (1992) 1.10